What is ADYX stock price today?

ADYX (Adynxx Inc) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ADYX stock going up or down today?

ADYX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADYX stock now?

The decision to buy ADYX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADYX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADYX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADYX stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ADYX is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ADYX's P/E ratio?

P/E ratio data for ADYX will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ADYX's market cap?

ADYX (Adynxx Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is ADYX's price to book ratio?

Price-to-book ratio for ADYX is available on our dashboard along with other valuation metrics.

Does ADYX pay dividends?

ADYX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADYX's dividend yield?

ADYX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADYX stock a good long-term investment?

ADYX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADYX's revenue growth rate?

Revenue growth data for ADYX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADYX are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADYX?

Key risks for ADYX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADYX compare to its competitors?

Compare ADYX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADYX's performance and positioning.

What is ADYX's stock price target for 2026?

Our AI model provides price targets for ADYX based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ADYX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADYX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADYX's next earnings report?

ADYX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADYX - Adynxx Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Adynxx Inc

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

ADYX Key Statistics

Market Cap

$0.00M

EPS

$-0.03

Employees

How ADYX Compares to Peers

ADYX is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ADYX(This stock)	$580.00	N/A	0%	0.0%	-
AMGNAmgen Inc	$178.24B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.99B	19.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.16B	31.1	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.69B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Adynxx Inc Company Information

Headquarters: 100 Pine Street, San Francisco, CA, United States, 94111, undefined
Website: www.adynxx.com
Sector: Healthcare
Industry: Biotechnology

Data Updated: January 21, 2026 at 2:41 AM EST

Ready to invest in ADYX?

Commission-free trading available. Affiliate links.

Upcoming Events for ADYX

Dashboard

Enter a ticker to analyze